Document is current

Any future updates will be listed below

Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2<sup>+</sup> T cells activities after hematopoietic transplantation for blood malignancies

Crossref DOI link: https://doi.org/10.1136/jitc-2019-000208

Published Online: 2020-03-26

Published Print: 2020-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark